See also this year's filing and all EDGAR filings for this company.
PDF Report 0001609809_2017_Seres_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001609809, Seres Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 198,369,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 36,125,000 |
| 3 | remainder_Assets | 38,152,000 |
| 4 | LiabilitiesCurrent | 30,457,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 109,558,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 32,616,000 |
| 9 | ResearchAndDevelopmentExpense | 81,989,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 21,766,000 |
| 12 | remainder_NetIncome | 1,260,000 |
| 13 | remainder_ComprehensiveNetIncome | -179,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 272,646,000 |
| 1 | Liabilities | 140,015,000 |
| 2 | Expenses | 114,605,000 |
| 3 | Revenues | 21,766,000 |
| 4 | StockholdersEquity | 132,631,000 |
| 5 | NetIncome | -91,579,000 |
| 6 | ComprehensiveNetIncome | -91,668,500 |
| 7 | BaseVar | 275,235,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.957 |
| 9 | EconomicCapitalRatio | 2.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
